PUBLISHED ON: October 13, 2009 | Duration: 1 min, 50 sec
While the ghost of USFDA has not gone away for Ranbaxy yet, it will have to face competition in the US for its drug Flomax. As US based Impax gets rights to sell Flomax, it is to compete with Ranbaxy in selling the drug.
